Protein and antibody microarray technology.

Antibody-based protein multiplex platforms: technical and operational challenges. Clin Chem (2009) 1.95

Microarrays of small molecules embedded in biodegradable polymers for use in mammalian cell-based screens. Proc Natl Acad Sci U S A (2004) 1.48

Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs. Am J Physiol Lung Cell Mol Physiol (2008) 1.46

Microarray methods for protein biomarker detection. Analyst (2008) 1.40

Application of photonic crystal enhanced fluorescence to cancer biomarker microarrays. Anal Chem (2011) 1.17

Signaling pathways of ESE-16, an antimitotic and anticarbonic anhydrase estradiol analog, in breast cancer cells. PLoS One (2013) 0.89

Advancing microarray assembly with acoustic dispensing technology. Anal Chem (2009) 0.87

Comparison of hydroxylated print additives on antibody microarray performance. J Proteome Res (2006) 0.86

Early lung cancer diagnosis by biosensors. Int J Mol Sci (2013) 0.84

Sensing lectin-glycan interactions using lectin super-microarrays and glycans labeled with dye-doped silica nanoparticles. Biosens Bioelectron (2013) 0.82

Multiplex immunoassay platforms based on shape-coded poly(ethylene glycol) hydrogel microparticles incorporating acrylic acid. Sensors (Basel) (2012) 0.78

The Transcriptomics to Proteomics of Hair Cell Regeneration: Looking for a Hair Cell in a Haystack. Microarrays (Basel) (2013) 0.75

A simple and sensitive assay for measuring very small volumes of microprinted solutions. Anal Chem Insights (2011) 0.75

Fabrication of a gel particle array in a microfluidic device for bioassays of protein and glucose in human urine samples. Biomicrofluidics (2011) 0.75

An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02

Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science (2009) 5.31

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood. Clin Cancer Res (2012) 2.07

Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infections. Proteomics (2005) 1.01

Multiplex approaches in protein microarray technology. Expert Rev Proteomics (2005) 0.97

Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res (2011) 0.93

Microarray technology as a universal tool for high-throughput analysis of biological systems. Comb Chem High Throughput Screen (2006) 0.86

Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget (2015) 0.75